EGFR and hepatocellular carcinoma: It possesses the ability to inhibit various targets, including epidermal growth factor receptor (EGFR), tyrosine kinase expressed in hepatocellular carcinoma (TEC), bone marrow kinase on chromosome X (BMX), and others [8].